Funding Announcements

FOAs and Notices Specific to COVID-19 and the Behavioral and Social Sciences

The following is a list of recently released NOSIs for Urgent Competitive Revisions and Administrative Supplements encouraging COVID-19 behavioral and social sciences research. Key areas of research encouraged by these NOSIs include various aspects of the Novel Coronavirus (SARS-CoV-2) and COVID-19 including risk communication, adherence to and transmission risks from various public health mitigation efforts, economic and social impacts from these mitigation efforts, downstream health and healthcare access effects as a result of these economic and social impacts, and interventions to ameliorate these downstream health impacts. In addition to a number of NIH institute or center (IC) NOSIs, OBSSR also has issued a trans-NIH NOSI to address common areas of interest across ICs and provide a mechanism for ICs to fund urgent competitive revisions and administrative supplements without publishing their own NOSI.

To sort by title, organization, dates or announcement number, click the table headers below.

Title Announcement Number Issuing Organization Opening Date Closing Date
Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency NOT-OD-20-118 NIH 202006106/10/2020 N/A
Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities NOT-MD-21-008 NIMHD 2020121712/17/2020 202201081/8/2022

OBSSR-Led FOAs and Notices

The OBSSR participates in and leads the following active funding announcements. Please note that this is not an exhaustive list of all funding announcements related to behavioral and social sciences research, but rather a list of those that OBSSR coordinates or has joined. OBSSR does not award grants. Please contact the NIH Institutes and Centers (IC) Research/Scientific contact(s) listed in these announcements for questions regarding IC funding interest in grant applications.

View the NIH Guide for Grants and Contracts for a complete list of all NIH funding announcements.

To sort by title, organization, dates or announcement number, click the table headers below.

Title Announcement Number Issuing Organization Opening Date Closing Date
National Science Foundation - National Institutes of Health NSF-NIH Interagency Initiative: Smart and Connected Health NOT-OD-18-149 OBSSR 201803093/9/2018 N/A
Notice of Information: National Death Index Linkage Access for NIH-Supported Investigators NOT-OD-20-057 OBSSR 202001141/14/2020 N/A
Notice of Interest in Long-term Maintenance of Behavior Change Research NOT-OD-19-040 OBSSR 2018121112/11/2018 N/A
Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions NOT-OD-20-106 OBSSR 202005195/19/2020 202209269/26/2022
Notice of Special Interest (NOSI): Research to Improve the Interpretation of Patient-Reported Outcomes at the Individual Patient Level for Use in Clinical Practice NOT-OD-20-079 OBSSR 202003243/24/2020 202305085/8/2023
Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health NOT-OD-21-100 OBSSR 202104084/8/2021 202406086/8/2024

OBSSR-Supported FOAs and Notices

The OBSSR participates in the following active funding announcements. Please note that this is not an exhaustive list of all funding announcements related to behavioral and social sciences research, but rather a list of those that OBSSR coordinates or has joined. OBSSR does not award grants. Please contact the NIH Institutes and Centers (IC) Research/Scientific contact(s) listed in these announcements for questions regarding IC funding interest in grant applications.

View the NIH Guide for Grants and Contracts for a complete list of all NIH funding announcements.

To sort by title, organization, dates or announcement number, click the table headers below.

Title Announcement Number Issuing Organization Opening Date Closing Date
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional) PA-18-945 NINR 201901051/5/2019 202201081/8/2022
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional) PA-18-946 NINR 201901161/16/2019 202201081/8/2022
Behavioral & Integrative Treatment Development Program (R01 Clinical Trial Optional) PAR-19-212 NIDA 201906236/23/2019 202203243/24/2022
Behavioral & Integrative Treatment Development Program (R34 Clinical Trial Optional) PAR-19-213 NIDA 201906236/23/2019 202203243/24/2022
Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional) PA-18-944 NINR 201901051/5/2019 202201081/8/2022
Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional) PA-18-943 NINR 201801161/16/2018 202201081/8/2022
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) PAR-20-111 NINDS 202003023/2/2020 202305085/8/2023
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) PAR-20-122 NINDS 202003033/3/2020 202305085/8/2023
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) PAR-19-274 NCI 201905085/8/2019 202205085/8/2022
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) PAR-19-276 NCI 201905165/16/2019 202205085/8/2022
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) PAR-19-275 NCI 201905165/16/2019 202205085/8/2022
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) PAR-20-255 NHGRI 202009199/19/2020 202307207/20/2023
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) PAR-20-254 NHGRI 202009199/19/2020 202307207/20/2023
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) PAR-20-257 NHGRI 202009199/19/2020 202307207/20/2023
Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) PAR-20-180 ODP 202004304/30/2020 202309089/8/2023
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional) PAR-19-200 NCCIH 201905055/5/2019 202205085/8/2022
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional) PAR-19-201 NCCIH 201905165/16/2019 202205085/8/2022
Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 Basic Experimental Studies with Humans Required) PAR-20-226 OppNet 202102162/16/2021 202303183/18/2023
Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 No Independent Clinical Trials) PAR-20-211 OppNet 202102162/16/2021 202303183/18/2023
Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards NOT-OD-20-055 NIH 202001171/17/2020 202303063/6/2023
Notice of Special Interest (NOSI): Implementation of Clinical Care Guidelines on Opioid Prescribing for Pain Management NOT-DA-20-038 NIDA 202004274/27/2020 202301081/8/2023
Notice of Special Interest (NOSI): Obesity Policy Evaluation Research (R01 Clinical Trial Not Allowed) NOT-DK-20-035 NIDDK 202007137/13/2020 202309089/8/2023
Notice of Special Interest in Research on the Health of Sexual and Gender Minority (SGM) Populations NOT-MD-19-001 NIMHD 201903133/13/2019 N/A
Notice of Special Interest in Understanding Factors in Infancy and Early Childhood (Birth to 24 months) That Influence Obesity Development NOT-DK-19-007 NIDDK 201901071/7/2019 N/A
Notice of Special Interest: Ancillary Reproductive Health Projects to Existing Large and/or Longitudinal Studies NOT-HD-20-008 NICHD 202004064/6/2020 202205025/2/2022
Notice of Special Interest: Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional) NOT-MD-20-011 NIMHD 202003273/27/2020 202209089/8/2022
Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional) PAR-20-266 NCCIH 202009029/2/2020 202306206/20/2023
Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional) PA-18-937 NINDS 201901051/5/2019 202201081/8/2022
Research on Chronic Overlapping Pain Conditions (R21 Clinical Trial Not Allowed) PA-18-939 NINDS 201901161/16/2019 202201081/8/2022
Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed) PAR-20-165 NINDS 202005055/5/2020 202303063/6/2023
Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed) PAR-20-168 NINDS 202004134/13/2020 202305085/8/2023
Research to Improve Native American Health (R21 Clinical Trials Optional) PAR-20-214 NIDA 202104174/17/2021 202309089/8/2023
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) PAR-20-238 NIDA 202104174/17/2021 202309089/8/2023
Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities NOT-MD-20-025 NIMHD 202008138/13/2020 202305085/8/2023
Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional) PAR-20-310 NIMHD 2020102710/27/2020 202303283/28/2023
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) PA-20-275 NCI 202007247/24/2020 202307247/24/2023
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) NOT-NS-20-107 NINDS 2020101910/19/2020 202405165/16/2024
Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional) PAR-21-081 NIMHD 202101051/5/2021 202301081/8/2023
Music and Health: Understanding And Developing Music Medicine (R21 Clinical Trial Optional) PAR-21-099 NINDS 202101161/16/2021 202302172/17/2023
Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional) PAR-21-100 NINDS 202101051/5/2021 202302062/6/2023
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) RFA-EY-21-001 NEI 202104024/2/2021 2023102810/28/2023
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-20-272 NCI 2020100910/9/2020 202307247/24/2023
BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) RFA-MH-20-620 NIMH 2020110711/7/2020 2022121012/10/2022
Notice of Special Interest (NOSI): Promoting Research on Interoception and Its Impact on Health and Disease NOT-AT-21-002 NCCIH 202101221/22/2021 202405075/7/2024
Notice of Special Interest (NOSI): Availability of Administrative Supplements for Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows NOT-OD-21-070 NIH 202103013/1/2021 202404084/8/2024
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) PAR-21-163 NINDS 202107107/10/2021 202405085/8/2024
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) PAR-21-162 NINDS 202107107/10/2021 202404064/6/2024
Notice of Special Interest (NOSI): Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being NOT-OD-21-087 ODP 202104064/6/2021 202402162/16/2024
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) RFA-MH-21-175 NIMH 202109089/8/2021 2023100710/7/2023
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) PAR-21-233 NINDS 202107107/10/2021 202404064/6/2024
NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed) RFA-NS-21-012 NINDS 2021071011/15/2021 2024040612/16/2023
Notice of Special Interest (NOSI): Navigating Pediatric to Adult Health Care: Lost in Transition NOT-HD-21-027 NICHD 202106056/5/2021 202401081/8/2024
BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) RFA-NS-21-026 NINDS 202106086/8/2021 2023100810/8/2023
BRAIN Initiative: Optimization of Transformative Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) RFA-NS-21-027 NINDS 202106086/8/2021 2023100810/8/2023
Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Basic Experimental Studies with Humans) PAR-21-280 OppNet 202202052/5/2022 202305085/8/2023
Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed) PAR-21-281 OppNet 202202052/5/2022 202305085/8/2023
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) PAR-21-303 FIC 2021101510/15/2021 2022121012/10/2022
American Women: Assessing Risk Epidemiologically (AWARE) (R01 Clinical Trial Optional) RFA-AI-21-058 NIAID 2021110911/9/2021 2021121012/10/2021
Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations NOT-MH-21-330 NIMH 2021100510/5/2021 202409089/8/2024
Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) PAR-21-315 NINDS 202109209/20/2021 202406216/21/2024
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required) PAR-21-349 OppNet 2021100510/5/2021 202406226/22/2024
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed) PAR-21-350 OppNet 2021100510/5/2021 202406226/22/2024
HEAL Initiative: Advancing Health Equity in Pain Management (R61/R33 Clinical Trial Required) RFA-NS-22-002 NINDS 2021100810/8/2021 2021121012/10/2021
NIH Blueprint for Neuroscience Research Short Courses in Neurotherapeutics Development (R25 Clinical Trial Not Allowed) RFA-NS-21-025 NINDS 2021110911/9/2021 2021121012/10/2021
NIH Health Care Systems Research Collaboratory - Pragmatic and Implementation Trials of Embedded Interventions (UG3/UH3, Clinical Trials Optional) RFA-AT-22-001 NCCIH 2021111511/15/2021 202206186/18/2022
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed) PAR-21-277 NIGMS 2021101810/18/2021 2023111611/16/2023
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Required) PAR-21-272 NINDS 202109279/27/2021 202409089/8/2024
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Basic Experimental Studies with Humans Required (BESH)) PAR-21-273 NINDS 202109279/27/2021 202409089/8/2024
Limited Competition: NIH Health Care Systems Research Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed) RFA-AT-22-002 NCCIH 2021111511/15/2021 2021121612/16/2021
HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional) RRFA-AT-22-004 NCCIH 2021111511/15/2021 2021121612/16/2021
HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Management Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required) RFA-AT-22-005 NCCIH 2021111511/15/2021 2021121612/16/2021
NIH HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional) RFA-DA-22-036 NIDA 202202022/2/2022 202203033/3/2022
Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed) PAR-22-072 NIMHD 202201051/5/2022 202405085/8/2024